AS-603

N/A

Report date: 2025/06/26 20:00:07
NME

Base Information

Drug NameAS-603
Drug Alias NameS-603AS-603AS-S603
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionBeta amyloid A4 protein modulatorsMicrotubule-associated protein tau modulators
TargetsBeta amyloid A4 proteinMicrotubule-associated protein tau
Therapy Area/IndicationsAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesAmyloid Solution Inc
China Registration ClassN/A

Develop Information

Active CompaniesAmyloid Solution Inc
Inactive CompaniesN/A
Active IndicationsAlzheimer Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A